FFRangio System vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

The FFRangio System is designed for real-time guidance during percutaneous coronary intervention (PCI) to optimize treatment for coronary artery disease. In contrast, the LINQ II Insertable Cardiac Monitor provides long-term, continuous monitoring of heart rhythms to diagnose arrhythmias. While both leverage AI in cardiology, they serve distinct clinical purposes, with one focusing on interventional procedures and the other on chronic rhythm monitoring.

Choose FFRangio System if…

Choose the FFRangio System if you require real-time, non-invasive functional assessment of coronary artery disease directly within the cath lab. This tool is ideal for optimizing percutaneous coronary intervention (PCI) decisions by providing wire-free FFR guidance, simulated pullback curves, and lesion impact analysis to confirm treatment effectiveness without additional invasive procedures or pharmacological agents.

View FFRangio System →

Choose LINQ II Insertable Cardiac Monitor if…

Choose the LINQ II Insertable Cardiac Monitor if your priority is long-term, continuous, and highly accurate detection of cardiac arrhythmias in an outpatient setting. This AI-powered device is best suited for patients requiring extended monitoring (up to 4.5 years) for conditions like unexplained syncope, cryptogenic stroke, or suspected paroxysmal atrial fibrillation, offering remote programming and data transmission for convenient patient management.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	LINQ II Insertable Cardiac Monitor
Pricing	Contact vendor for pricing information.	Unknown
Deployment	SaaS, on-prem, hybrid	Subcutaneous implant with remote monitoring via mobile app or home communicator.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	LINQ II Insertable Cardiac Monitor
Name	FFRangio System	LINQ II Insertable Cardiac Monitor
Company	CathWorks	Medtronic
Tagline	A New Era in Coronary Physiology	Advanced insertable cardiac monitoring with AI-powered accuracy and remote management.
Primary Function	Wire-free and drug-free 3D FFR guidance for optimizing PCI decisions.	Long-term, continuous heart rhythm monitoring with remote programming and AI-powered accuracy for diagnosing arrhythmias.
Specialties	Cardiology	Cardiology
Categories	Cardiology AI, Surgical AI	Cardiology AI, Clinical Decision Support & Reference

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for the FFRangio System versus the LINQ II Insertable Cardiac Monitor?

The FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize PCI decisions for patients with coronary artery disease. In contrast, the LINQ II Insertable Cardiac Monitor offers long-term, continuous heart rhythm monitoring for diagnosing arrhythmias.

How does each tool leverage artificial intelligence to assist physicians?

The FFRangio System utilizes AI to aid in quick angiogram analysis, providing real-time FFRangio values and advanced insights. The LINQ II Insertable Cardiac Monitor employs AccuRhythm AI algorithms for enhanced accuracy in detecting and diagnosing arrhythmias.

What is the nature of the patient procedure and level of invasiveness associated with each tool?

The FFRangio System is used during a cath lab procedure, offering a non-invasive approach to FFR measurement by eliminating the need for invasive pressure wires or drugs. The LINQ II is an insertable cardiac monitor, requiring a minor procedure for implantation to provide continuous monitoring.

What is the duration and type of monitoring or guidance each system provides?

The FFRangio System provides real-time FFRangio values and guidance during a coronary intervention. The LINQ II Insertable Cardiac Monitor offers long-term, continuous heart rhythm monitoring for up to 4.5 years.

How do these tools integrate into existing clinical workflows and infrastructure?

The FFRangio System is an on-premise solution that seamlessly integrates with cath lab equipment, C-arm angiography systems, and PACS. The LINQ II offers a hybrid deployment model with remote programming and data transmission via the MyCareLink Heart mobile app or MyCareLink Relay home communicator.

What unique features does each device offer that could impact patient management or experience?

The FFRangio System provides features like a simulated pullback curve, lesion impact assessment, and an integrated sizing tool for non-invasive lesion measurements. The LINQ II offers MRI compatibility (1.5 and 3.0T), remote programming capability, and a pediatric indication for ages 2 and up.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform